Clinical Trial News and Research

RSS

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Spectral Diagnostics Inc., today announced its financial results for the third quarter ended September 30, 2009.

12 Nov 2009

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Bradmer Pharmaceuticals Inc. today announced its 2009 third quarter financial results.

12 Nov 2009

Keryx Biopharmaceuticals to present KRX-0401 Phase 1/2 clinical trial data at the ASH meeting

Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.

12 Nov 2009

Trubion Pharmaceuticals to present data on its TRU-016 product candidate at the ASH meeting

Trubion Pharmaceuticals, Inc. announced today the acceptance of two data presentations on its product candidate, TRU-016, at the 2009 American Society of Hematology (ASH) Annual Meeting Dec. 5-8, 2009 in New Orleans, Louisiana.

12 Nov 2009

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Four macaque monkeys that received injections of genes for a protein called follistatin into upper leg muscles experienced pronounced and durable increases in muscle size and strength and no adverse effects, the Muscular Dystrophy Association (MDA) announced today. The findings could have implications particularly for injured and aging people worldwide; and for tens of millions experiencing muscle loss associated with cancer, AIDs and muscle diseases.

12 Nov 2009

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.

12 Nov 2009

PIKAMAB announces the development of ADCC Therasight, a novel theragnostic product

PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it is developing ADCC TherasightTM, a novel theragnostic product that can help guide the drug development process and patient treatment protocols for the cancer therapeutic antibodies that use ADCC (antibody-dependent cellular cytotoxicity) as the major mechanism of action.

12 Nov 2009

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Amarillo Biosciences, Inc. reported that the American Veterinary Medical Association (AVMA) recently confirmed that a household cat in Iowa developed signs of respiratory infection caused by H1N1 influenza virus.

12 Nov 2009

Data from Phase IIa clinical trial evaluating VT-111 to be presented by Viron Therapeutics at AHA conference

Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced today that the Company's research collaborator, Dr. Jean-Claude Tardif, Director of the Research Center at the Montreal Heart Institute, will present data from a Phase IIa clinical trial evaluating VT-111 at the American Heart Association (AHA) Scientific Sessions 2009 conference. The conference will take place in Orlando, Florida from November 14 to 18, 2009.

12 Nov 2009

Dark chocolates reduce stress levels

The "chocolate cure" for emotional stress is getting new support from a clinical trial published online in ACS' Journal of Proteome Research. It found that eating about an ounce and a half of dark chocolate a day for two weeks reduced levels of stress hormones in the bodies of people feeling highly stressed. Everyone's favorite treat also partially corrected other stress-related biochemical imbalances.

12 Nov 2009

Gene delivery strategy to help improve muscle mass in patients with degenerative muscle disorders

Severe weakness of the quadriceps is a defining feature of several neuromuscular disorders. Researchers at Nationwide Children's Hospital have shown that a gene delivery strategy that produces follistatin - a naturally occurring protein that inhibits myostatin, a growth factor expressed specifically in skeletal muscle - directly to the quadriceps of non-human primates results in long-term gene expression with muscle enhancing effects, including larger muscles with greater strength.

12 Nov 2009

ResearchMatch: A free meeting place for researchers

A new national initiative involving UT Southwestern Medical Center will match volunteers who want to take part in medical research studies with the scientists who are leading those studies.

12 Nov 2009

New biopharmaceutical business intelligence tool from Deloitte Recap

Deloitte Recap LLC (Recap) has launched "Development Optimizer," the third product in the Recap IQ Series by Deloitte. The series of biopharmaceutical business intelligence tools are part of a new subscription service tailored toward business development, corporate strategy, financial, clinical development, legal, academic and R&D professionals.

11 Nov 2009

TGA approves OrthoAccel Technologies' application to market AcceleDent System in Australia

OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced that its application to market and distribute the product for sale was approved by Australia's Therapeutic Goods Administration (TGA). AcceleDent is classified as an, "orthodontic appliance system," in Australia.

11 Nov 2009

Positive results from Puricore's Vashe Wound Therapy efficacy trial

PuriCore, the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, today announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries.

11 Nov 2009

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries -- strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.

11 Nov 2009

Prone ventilation for ARDS patients does not lower mortality rate, says new study

Despite a current suggestion that patients with acute respiratory distress syndrome be positioned lying face down while receiving mechanical ventilation, study results indicate that this positioning does not significantly lower the risk of death compared to similar patients positioned lying face up during ventilation, according to a study in the November 11 issue of JAMA.

11 Nov 2009

BioClinica to host a seminar on medical imaging for rheumatoid arthritis in clinical trials

BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced it will be hosting a seminar on November 18, 2009 highlighting new research, trends and updates from industry experts in rheumatoid arthritis. This event, which will be held in Lafayette, PA, is part of the continuing series of symposia hosted by the company for pharmaceutical and medical imaging executives over the past four years that addresses the challenges and approaches in conducting clinical trials.

From Clario 11 Nov 2009

New incisionless GERD treatment under trial

Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.

11 Nov 2009

Particle Sciences expands operations by acquiring new additional space

Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft.

11 Nov 2009

Clinical Trial News and Research

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Keryx Biopharmaceuticals to present KRX-0401 Phase 1/2 clinical trial data at the ASH meeting

Trubion Pharmaceuticals to present data on its TRU-016 product candidate at the ASH meeting

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

PIKAMAB announces the development of ADCC Therasight, a novel theragnostic product

AVMA confirms that a household cat in Iowa showed signs of H1N1 influenza

Data from Phase IIa clinical trial evaluating VT-111 to be presented by Viron Therapeutics at AHA conference

Dark chocolates reduce stress levels

Gene delivery strategy to help improve muscle mass in patients with degenerative muscle disorders

ResearchMatch: A free meeting place for researchers

New biopharmaceutical business intelligence tool from Deloitte Recap

TGA approves OrthoAccel Technologies' application to market AcceleDent System in Australia

Positive results from Puricore's Vashe Wound Therapy efficacy trial

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

Prone ventilation for ARDS patients does not lower mortality rate, says new study

BioClinica to host a seminar on medical imaging for rheumatoid arthritis in clinical trials

New incisionless GERD treatment under trial

Particle Sciences expands operations by acquiring new additional space

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer